Effects of danazol on DNA synthesis in rat prostate

The Prostate · 1993 · vol. 22(2) , pp. 119–124 · doi:10.1002/pros.2990220204 · PMID:8456051 · W2139061553
Lab / animal OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Danazol was found to reduce DNA synthesis enzyme activities and bromodeoxyuridine-immunoreactive cells in rat prostate, alongside decreased luteinizing hormone, testosterone, and organ weight.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Effects of danazol, an isoxazol derivative of the synthetic steroid 17 alpha-ethinyltestosterone, on activities of thymidylate synthetase and thymidine kinase, which are the DNA-synthesizing enzymes included in de novo and salvage pathways of pyrimidine metabolism, respectively, were investigated in rat prostate. Danazol markedly reduced plasma levels of luteinizing hormone and testosterone, and organ weight, both enzyme activities and bromodeoxyuridine-immunoreactive cells which were regarded as the S-phase cells in prostate. These results indicate that danazol shows a property as a potent antigonadotropin.

My notes (saved in your browser only)

MeSH descriptors

Danazol DNA Prostate Thymidine Kinase Thymidylate Synthase Animals Bromodeoxyuridine Danazol DNA Follicle Stimulating Hormone Follicle Stimulating Hormone Immunohistochemistry Luteinizing Hormone Luteinizing Hormone Male Organ Size Organ Size Prostate Prostate Prostate

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (20)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-14T06:05:00.350814+00:00
pubmed
last seen: 2026-10-08T21:59:37.277143+00:00
License: CC0 · commercial use OK